新西兰药房改变了19种药品,以降低成本,确保病人在过渡期间得到支助。 New Zealand's Pharmac alters 19 medicines to cut costs, ensuring patient support through transitions.

新西兰药房宣布,经过一个旨在降低成本和释放新药品资金的公共协商进程,对19种资金资助的药品进行了修改。 New Zealand's Pharmac has announced changes to 19 funded medicines following a public consultation process aimed at reducing costs and freeing up funds for new medicines. 这些变化,包括品牌开关,是旨在提高成本效益的年度招标进程的一部分。 The changes, which include brand switches, are part of an annual tender process designed to increase cost-effectiveness. 药剂师通过与用户、保健专业人员和倡导团体协商,强调以病人为中心的决定,以确保更顺利的过渡。 Pharmac emphasized patient-centric decisions by consulting with users, healthcare professionals, and advocacy groups to ensure smoother transitions. 该机构将提供资源和支持,帮助病人和医生管理这些变化。 The agency will provide resources and support to help patients and doctors manage the changes.